Download PDF
Semin Thromb Hemost 2002; 28(2): 227-238
DOI: 10.1055/s-2002-27824
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Acquired von Willebrand Syndrome: Experience from 2 Years in a Single Laboratory Compared with Data from the Literature and an International Registry

Ulrich Budde1 , Frauke Bergmann1 , Jan J. Michiels2
  • 1Coagulation Laboratory, Lab. Association Prof. Arndt and Partners, Hamburg, Germany
  • 2Hemostasis and Thrombosis Research, Department of Hematology, University Hospital Antwerp and University Hospital Rotterdam and Goodheart Institute, Hemostasis and Thrombosis Science Center, Rotterdam, The Netherlands
Further Information

Publication History

Publication Date:
03 May 2002 (online)

    Permissions and Reprints

ABSTRACT

Acquired von Willebrand syndrome (avWS) has gained more attention during the last years. An International Registry has been compared with the literature. It could be shown that the data collected from 123 publications compared well with the data from the registry, albeit with differences in the number of patients suffering from lymphoproliferative diseases and cardiovascular disorders, that were more prominent in the registry and the group of miscellaneous conditions underrepresented in the registry. Our data are clearly different for the lymphoproliferative diseases with only four patients in 2 years. These patients usually suffer from severe bleeding complications together with low to very low factor VIII/von Willebrand factor (FVIII/vWF) concentrations and thus will not go undiagnosed. In contrast to this, patients with cardiovascular disorders usually bleed only during surgical procedures or catheter procedures. At that time they have increased vWF parameters. Because of this and because the acute bleeding is of limited duration and usually not life threatening, many of them are discharged without a proper diagnosis and are only rarely referred to a specialized diagnostic work-up thereafter. In conclusion, avWS, although not a frequent disease, is nevertheless clearly underdiagnosed. This should be addressed in future prospective studies.

KEYWORDS

Acquired von Willebrand syndrome - von Willebrand factor - lymphoproliferative disorders - myeloproliferative disorders - cardiovascular defects - miscellaneous conditions

REFERENCES

  • 1 Sadler J E, Mannucci P M, Berntorp E. Impact, diagnosis and treatment of von Willebrand disease.  Thromb Haemost . 2000;  84 160-174
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Ruggeri Z M. Structure and function of von Willebrand factor.  Thromb Haemost . 1999;  82 576-584
    PubMedGoogle Scholar
  • 3 von Willebrand A E. Hereditär pseudohemofili.  Finska Läk Sällsk Handl . 1926;  68 87-112
    PubMedGoogle Scholar
  • 4 Simone J V, Cornet J A, Abildgaard C F. Acquired von Willebrand's syndrome in systemic lupus erythematosus.  Blood . 1968;  31 806-811
    CrossrefPubMedGoogle Scholar
  • 5 Ingram G IC, Kingston P J, Leslie J, Bowie E JW. Four cases of acquired von Willebrand's syndrome.  Br J Haematol . 1971;  21 189-199
    CrossrefPubMedGoogle Scholar
  • 6 Mant M J, Gauldie H J, Bienestock G J, Pineo G F, Luke K H. Von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy.  Blood . 1973;  42 429-436
    PubMedGoogle Scholar
  • 7 Joist J H, Cowan J F, Zimmerman T S. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.  N Engl J Med . 1978;  298 988-991
    CrossrefPubMedGoogle Scholar
  • 8 Brody J I, Haidar M E, Rossman R. A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII.  N Engl J Med . 1979;  300 408-410
    PubMedGoogle Scholar
  • 9 Noronha P A, Hruby M A, Maurer H S. Acquired von Willebrand disease in a patient with Wilms tumor.  J Pediatr . 1979;  95 997-999
    PubMedGoogle Scholar
  • 10 Budde U, Schäfer G, Müller N. Acquired von Willebrand's disease in the myeloproliferative syndrome.  Blood . 1984;  64 981-985
    PubMedGoogle Scholar
  • 11 Gill J C, Wilson A D, Endres-Brooks J, Montgomery R R. Loss of the largest von Willebrand factor multimers from plasma of patients with congenital cardiac defects.  Blood . 1986;  67 758-761
    CrossrefPubMedGoogle Scholar
  • 12 Dalton R G, Dewar M S, Savidge G F. Hypothyroidism as a cause of acquired von Willebrand's disease.  Lancet . 1987;  1 1007-1009
    PubMedGoogle Scholar
  • 13 Kinoshita S, Yoshioka K, Kasahara M, Takamiya O. Acquired von Willebrand disease after Epstein-Barr virus infection.  J Pediatr . 1991;  119 595-598
    PubMedGoogle Scholar
  • 14 Jakway J L. Acquired von Willebrand's disease in malignancy.  Semin Thromb Hemost . 1992;  18 434-439
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Rinder M R, Richard R E, Rinder H M. Acquired von Willebrand's disease: a concise review.  Am J Hematol . 1997;  54 139-145
    PubMedGoogle Scholar
  • 16 Tefferi A, Nichols W L. Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis and treatment.  Am J Med . 1997;  103 536-540
    CrossrefPubMedGoogle Scholar
  • 17 Michiels J J, Budde U, van Genderen J J P. Acquired von Willebrand syndromes: clinical features, etiology, pathophysiology, classification and management.  Baillères Clin Haematol (in press) . 2001; 
    PubMedGoogle Scholar
  • 18 Veyradier A, Jenkins C SP, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management.  Thromb Haemost . 2000;  84 175-182
    PubMedGoogle Scholar
  • 19 Federici A B, Rand J H, Bucciarelli P. Acquired von Willebrand syndrome: data from an international registry.  Thromb Haemost . 2000;  84 345-349
    PubMedGoogle Scholar
  • 20 Hoylaerts M F, Thys C, Arnout J, Vermylen J. Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc gamma RII receptor-mediated platelet activation.  Blood . 1998;  91 2810-2817
    PubMedGoogle Scholar
  • 21 van Genderen J J P, Vink T, Michiels J J. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen.  Blood . 1994;  84 3378-3384
    PubMedGoogle Scholar
  • 22 Stewart M W, Etches W S, Shaw A RE, Gordon P A. vWF inhibitor detection by competitive ELISA.  J Immunol Methods . 1997;  200 113-119
    CrossrefPubMedGoogle Scholar
  • 23 Zettervall O, Nilsson I M. Acquired von Willebrand's disease caused by monoclonal antibody.  Acta Med Scand . 1978;  204 521-528
    PubMedGoogle Scholar
  • 24 Hartleib J, Köhler N, Dickinson R B. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus Blood .  2000;  96 2149-2156
    PubMedGoogle Scholar
  • 25 Luboshitz J, Lubetsky A, Schliamser L. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.  Thromb Haemost . 2001;  85 806-809
    PubMedGoogle Scholar
  • 26 Federici A B, Stabile F, Castaman G, Canciani M T, Mannucci P M. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.  Blood . 1998;  92 2707-2711
    PubMedGoogle Scholar
  • 27 Horellou M H, Baumelou E, Sitbon N. Quatre cas de deficit acquis en facteur Willebrand associés a une dysgulobulinémie monoclonale.  Ann Med Interne (Paris) . 1983;  143 707-712
    PubMedGoogle Scholar
  • 28 Van Genderen J J P, Terpstra W, Michiels J J, Kapteijn L, van Vliet H D M H. High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease.  Thromb Haemost . 1995;  73 891-892
    PubMedGoogle Scholar
  • 29 Gunz F W. Hemorrhagic thrombocythemia. A critical review.  Blood . 1960;  15 706-723
    PubMedGoogle Scholar
  • 30 Van Genderen J J P, Michiels J J. Erythromelalgic, thrombotic and hemorrhagic thrombocythemia.  Press Med . 1994;  23 73-77
    PubMedGoogle Scholar
  • 31 Fabris F, Casonato A, Del Ben G M, De Marco L, Girolami A. Abnormalities of von Willebrand factor in myeloproliferative disease: A relationship with bleeding diathesis.  Br J Haematol . 1986;  63 75-83
    CrossrefPubMedGoogle Scholar
  • 32 Casonato A, Fabris F, Zancan L, Girolami A. Acquired type I von Willebrand's disease in a patient with essential thrombocytosis.  Acta Haematol . 1986;  75 188-189
    CrossrefPubMedGoogle Scholar
  • 33 Zimmerman T S, Dent J A, Ruggeri Z M, Nannini L H. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID and IIE).  J Clin Invest . 1986;  77 947-951
    CrossrefPubMedGoogle Scholar
  • 34 Budde U, Dent J A, Berkowitz S D, Ruggeri Z M, Zimmerman T S. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome.  Blood . 1986;  68 1213-1217
    PubMedGoogle Scholar
  • 35 Van Genderen J J P, Michiels J J, van der Poel-van de Luitgaarde SC P A M, van Vliet H D M H. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia.  Ann Hematol . 1994;  69 81-84
    CrossrefPubMedGoogle Scholar
  • 36 Budde U, Scharf R E, Franke P. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma.  Blood . 1993;  82 749-757
    PubMedGoogle Scholar
  • 37 Van Genderen J J P, Budde U, Michiels J J, van Strik R, van Vliet H D M H. The reduction of large von Willebrand factor multimers in patients with essential thrombocythemia is related to the platelet count.  Br J Haematol . 1996;  93 962-965
    CrossrefPubMedGoogle Scholar
  • 38 Coppes M J, Zandvoort S WH, Sparling C R. Acquired von Willebrand disease in Wilms' tumor patients.  J Clin Oncol . 1992;  10 422-427
    PubMedGoogle Scholar
  • 39 Anderson R P, McGrath K, Street A. Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement.  Lancet . 1996;  347 689-690
    PubMedGoogle Scholar
  • 40 Knobloch W, Hauser E, Niehues R. Calcifying aortic valve stenosis and cryptogenic gastrointestinal bleeding (Heyde syndrome): report of two cases.  Z Kardiol . 1999;  88 448-453
    CrossrefPubMedGoogle Scholar
  • 41 Pareti F I, Lattuada A, Bressi C. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis.  Circulation . 2000;  102 1290-1295
    CrossrefPubMedGoogle Scholar
  • 42 Heyde E C. Gastrointestinal bleeding in aortic stenosis.  N Engl J Med . 1958;  259 196-201
    PubMedGoogle Scholar
  • 43 Warkentin T E, Moore J C, Morgan D G. Aortic stenosis and bleeding gastrointestinal angiodysplasia-is acquired von Willebrand's disease the link?.  Lancet . 1992;  340 35-37
    CrossrefPubMedGoogle Scholar
  • 44 Van Genderen J J P, Prins F J, Lucas I S, van de Moesdijk D, van Vliet H D M H. Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythemia: normalization after cytoreduction of the increased platelet count.  Br J Haematol . 1997;  99 832-836
    CrossrefPubMedGoogle Scholar
  • 45 Gill J C, Endres-Brooks J, Bauer P J, Marks W J, Montgomery R R. The effect of ABO blood group on the diagnosis of von Willebrand disease.  Blood . 1987;  69 1691-1695
    CrossrefPubMedGoogle Scholar
  • 46 Beacham D A, Lian J, Konkle B A, Ludlow L B, Shapiro S S. Arterial shear stress stimulates surface expression of the endothelial glycoprotein IB complex.  J Cell Biochem . 1999;  73 508-521
    CrossrefPubMedGoogle Scholar
  • 47 Galbusera M, Zoja C, Donadelli R. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium.  Blood . 1997;  90 1558-1564
    PubMedGoogle Scholar
  • 48 Rosendaal F R. High levels of factor VIII and venous thrombosis.  Thromb Haemost . 2000;  83 1-2
    PubMedGoogle Scholar
  • 49 Catto A J, Carter A M, Barrett J H. Von Willebrand factor and factor VIII:C in acute cerebrovascular disease-relationship to stroke subtype and mortality.  Thromb Haemost . 1997;  77 1104-1108
    PubMedGoogle Scholar
  • 50 Kreuz W, Linde R, Funk M. Induction of von Willebrand disease type 1 by valproic acid.  Lancet . 1990;  335 178-184
    PubMedGoogle Scholar
  • 51 Strauss R G, Stump D C, Henriksen R A. Hydroxyethyl starch accentuates von Willebrand's disease.  Transfusion . 1985;  25 235-237
    CrossrefPubMedGoogle Scholar
  • 52 Benson P J, Peterson L C, Hasegawa D K, Smith C M. Abnormality of von Willebrand factor in patients with hemoglobin E-β thalassemia.  Am J Clin Pathol . 1990;  93 395-399
    PubMedGoogle Scholar
  • 53 Eberl W, Budde U, Bergmann F. Das erworbene von Willebrand Syndrom bei Valproattherapie ist selten.  Klin Päd (Abst) . 2001;  213 S28
    PubMedGoogle Scholar
  • 54 Gralnick H R, McKeown L P, Willimas S B, Shafer B C. Plasma and platelet von Willebrand factor: defects in uremia.  Am J Med . 1988;  85 806-810
    CrossrefPubMedGoogle Scholar
  • 55 Zwaginga J J, Ijsseldijk M JW, Beeser-Visser N. High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood.  Blood . 1990;  75 1498-1508
    PubMedGoogle Scholar
  • 56 Dentale N, Fulgaro C, Guerra L. Acquisition of factor VIII inhibitor after acute hepatitis C virus infection.  Blood . 1997;  90 3233-3234
    PubMedGoogle Scholar
      >